Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers
Editorial Group: Cochrane Haematological Malignancies Group
Published Online: 5 OCT 2011
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Friis IS, Kochanek M, Monsef I, Skoetz N, Engert A, Bauer K. Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 10. Art. No.: CD009357. DOI: 10.1002/14651858.CD009357.
- Publication Status: New
- Published Online: 5 OCT 2011
This is the protocol for a review and there is no abstract. The objectives are as follows:
We will evaluate the efficacy of intravenous immunoglobulin (IVIG) in the treatment of infections in patients with haematological malignancies with respect to the duration of infections, study mortality, infection-related mortality, adverse events, infection and duration of hospitalisation.